Increased LRG1 expression in the serum has been demonstrated in ovarian cancer [12], non-small cell lung cancer [13], gastric cancer [14], pancreatic cancer [15], and leukemia [16]. This evidence concerns the gene LRG1 and familial pancreatic carcinoma.